PuSH - Publication Server of Helmholtz Zentrum München

36 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Fernandez, I.E. et al.: Myeloid-derived suppressor cells orchestrate immunosuppressive networks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 199 (2019)
2.
Kahnert, K.* et al.: Adherence to respiratory and non-respiratory medication in patients with COPD: Results of the German COSYCONET cohort. Internist 60, S5-S6 (2019)
3.
Moore, C.* et al.: Resequencing study confirms host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med., accepted (2019)
4.
Staab-Weijnitz, C.A. et al.: Quantitative proteomic profiling of extracellular matrix and collagen posttranslational modifications in an in vitro model of lung fibrosis. Am. J. Respir. Crit. Care Med. 199 (2019)
5.
von Siemens, M.* et al.: Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: Results from the COSYCONET cohort study. Internist 60, S49-S49 (2019)
6.
von Siemens, S.M.* et al.: Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: Results from the COSYCONET cohort study. Respir. Res. 20:30 (2019)
7.
Burgstaller, G. et al.: Distinct niches within the extracellular matrix dictate fibroblast function in (cell free) 3D lung tissue cultures. Am. J. Physiol. Lung Cell Mol. Physiol. 314, L708-L723 (2018)
8.
Fernandez, I.E. et al.: Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks. Eur. Respir. J. 52 (2018)
9.
Greiffo, F.R. et al.: Fractalkine/CX3CR1 axis drives kinetic changes of monocytes in fibrotic Interstitial Lung Disease. In: Abstract submission (American Thoracic Society (ATS) International Conference 2018, 18-23 May 2018, American Thoracic Society (ATS) International Conference 2018). 2018.:13993 - Fractalkine/CX3CR1 Axis ( ; Annual)
10.
Heinzelmann, K. et al.: Cell-surface phenotyping identifies CD36 and CD97 as novel markers of fibroblast quiescence in lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 315, L682-L696 (2018)
11.
Heinzelmann, K. et al.: DPPIV expression in human lung fibroblasts affects phenotypic changes in fibrosis. Am. J. Respir. Crit. Care Med. 197 (2018)
12.
Kahnert, K.* et al.: The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir. Med. 134, 79-85 (2018)
13.
Knüppel, L. et al.: FK506-binding protein 10 (FKBP10) regulates lung fibroblast migration via collagen VI synthesis. Respir. Res. 19:67 (2018)
14.
Knüppel, L. et al.: A proteomic analysis of extracellular matrix from idiopathic pulmonary fibrosis patient-derived fibroblasts in response to transforming growth factor beta 1. Am. J. Respir. Crit. Care Med. 197 (2018)
15.
Knüppel, L. et al.: FKBP10 regulates fibroblast migration via synthesis of collagen VI. Eur. Respir. J. 52 (2018)
16.
Kreuter, M.* et al.: Diagnosis and management of patients with interstitial lung disease (ILD) in clinical practice in Germany: Exciting-ILD registry. Am. J. Respir. Crit. Care Med. 197 (2018)
17.
Kreuter, M.* et al.: Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry. Eur. Respir. J. 52 (2018)
18.
Lehmann, M. et al.: Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis. Respir. Res. 19:175 (2018)
19.
Leuschner, G.* et al.: Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy. J. Heart Lung Transpl. 37, 268-274 (2018)
20.
Matthes, S.* et al.: Asthma features in severe COPD: Identifying treatable traits. Respir. Med. 145, 89-94 (2018)